Cargando…
New Drugs Bringing New Challenges to AML: A Brief Review
The better understanding of the genomic landscape in acute myeloid leukaemia (AML) has progressively paved the way for precision medicine in AML. There is a growing number of drugs with novel mechanisms of action and unique side-effect profiles. This review examines the impact of evolving novel ther...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537004/ https://www.ncbi.nlm.nih.gov/pubmed/34683144 http://dx.doi.org/10.3390/jpm11101003 |
_version_ | 1784588144543268864 |
---|---|
author | Yeoh, Zhi Han Bajel, Ashish Wei, Andrew H. |
author_facet | Yeoh, Zhi Han Bajel, Ashish Wei, Andrew H. |
author_sort | Yeoh, Zhi Han |
collection | PubMed |
description | The better understanding of the genomic landscape in acute myeloid leukaemia (AML) has progressively paved the way for precision medicine in AML. There is a growing number of drugs with novel mechanisms of action and unique side-effect profiles. This review examines the impact of evolving novel therapies on survival in AML and the challenges that ensue. |
format | Online Article Text |
id | pubmed-8537004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85370042021-10-24 New Drugs Bringing New Challenges to AML: A Brief Review Yeoh, Zhi Han Bajel, Ashish Wei, Andrew H. J Pers Med Review The better understanding of the genomic landscape in acute myeloid leukaemia (AML) has progressively paved the way for precision medicine in AML. There is a growing number of drugs with novel mechanisms of action and unique side-effect profiles. This review examines the impact of evolving novel therapies on survival in AML and the challenges that ensue. MDPI 2021-10-03 /pmc/articles/PMC8537004/ /pubmed/34683144 http://dx.doi.org/10.3390/jpm11101003 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Yeoh, Zhi Han Bajel, Ashish Wei, Andrew H. New Drugs Bringing New Challenges to AML: A Brief Review |
title | New Drugs Bringing New Challenges to AML: A Brief Review |
title_full | New Drugs Bringing New Challenges to AML: A Brief Review |
title_fullStr | New Drugs Bringing New Challenges to AML: A Brief Review |
title_full_unstemmed | New Drugs Bringing New Challenges to AML: A Brief Review |
title_short | New Drugs Bringing New Challenges to AML: A Brief Review |
title_sort | new drugs bringing new challenges to aml: a brief review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537004/ https://www.ncbi.nlm.nih.gov/pubmed/34683144 http://dx.doi.org/10.3390/jpm11101003 |
work_keys_str_mv | AT yeohzhihan newdrugsbringingnewchallengestoamlabriefreview AT bajelashish newdrugsbringingnewchallengestoamlabriefreview AT weiandrewh newdrugsbringingnewchallengestoamlabriefreview |